Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL-1186 for Postoperative Pain in Abdominal Surgery
NCT07311369Phase 2Recruiting
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HL-1186 in postoperative pain, sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.. Started Dec 2025; status: recruiting.
02
Drugs
HL-1186
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07311369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311369.